serw-MX  [xml]  
 


    
 DeCS Categories

D02 Organic Chemicals .
D02.455 Hydrocarbons .
D02.455.426 Hydrocarbons, Cyclic .
D02.455.426.559 Hydrocarbons, Aromatic .
D02.455.426.559.847 Polycyclic Aromatic Hydrocarbons .
D02.455.426.559.847.486 Indenes .
D02.455.426.559.847.486.875 Sulindac .
D02.455.426.559.847.562 Naphthacenes .
D02.455.426.559.847.562.050 Anthracyclines .
D02.455.426.559.847.562.050.050 Aclarubicin .
D02.705 Organophosphorus Compounds .
D02.705.429 Organophosphonates .
D02.705.429.500 Diphosphonates .
D02.705.429.500.100 Alendronate .
D02.886 Sulfur Compounds .
D02.886.675 Thiazoles .
D02.886.675.215 Famotidine .
D03 Heterocyclic Compounds .
D03.383 Heterocyclic Compounds, 1-Ring .
D03.383.129 Azoles .
D03.383.129.708 Thiazoles .
D03.383.129.708.215 Famotidine .
D03.633 Heterocyclic Compounds, Fused-Ring .
D03.633.100 Heterocyclic Compounds, 2-Ring .
D03.633.100.531 Isoquinolines .
D03.633.100.531.085 Benzylisoquinolines .
D03.633.100.531.085.888 Tretoquinol .
D04 Polycyclic Compounds .
D04.615 Polycyclic Aromatic Hydrocarbons .
D04.615.486 Indenes .
D04.615.486.875 Sulindac .
D04.615.562 Naphthacenes .
D04.615.562.050 Anthracyclines .
D04.615.562.050.050 Aclarubicin .
D09 Carbohydrates .
D09.408 Glycosides .
D09.408.051 Aminoglycosides .
D09.408.051.059 Anthracyclines .
D09.408.051.059.050 Aclarubicin .
D12 Amino Acids, Peptides, and Proteins .
D12.644 Peptides .
D12.644.456 Oligopeptides .
D12.644.456.810 Teprotide .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Famotidine .
Famotidine Hydrochloride .
MK-208 .
Pepcid .
YM-11170 .
MK 208 .
MK208 .
YM 11170 .
YM11170 .
A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion. .
1.00
261551
 
Alendronate .
4-Amino-1-Hydroxybutylidene 1,1-Biphosphonate .
Alendronate Monosodium Salt, Trihydrate .
Alendronate Sodium .
Aminohydroxybutane Bisphosphonate .
Fosamax .
MK-217 .
4 Amino 1 Hydroxybutylidene 1,1 Biphosphonate .
Bisphosphonate, Aminohydroxybutane .
MK 217 .
MK217 .
Sodium, Alendronate .
A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis. .
0.55
1423338
 
Sulindac .
Aclin .
Apo-Sulin .
Arthrobid .
Arthrocine .
Chibret .
Clinoril .
Copal .
Kenalin .
Klinoril .
MK-231 .
Novo-Sundac .
Nu-Sulindac .
Sulindal .
Apo Sulin .
MK 231 .
MK231 .
Novo Sundac .
Nu Sulindac .
A sulfinylindene derivative prodrug whose sulfinyl moiety is converted in vivo to an active NSAID analgesic. Specifically, the prodrug is converted by liver enzymes to a sulfide which is excreted in the bile and then reabsorbed from the intestine. This helps to maintain constant blood levels with reduced gastrointestinal side effects. .
0.55
261301
 
Tretoquinol .
AQ-110 .
AQL-208 .
CV-705 .
Tetroquinol .
Tretoquinol Hydrochloride .
Tretoquinol Hydrochloride Anhydrous .
Tretoquinol Hydrochloride, (S)-Isomer .
Tretoquinol-(R) .
Tretoquinol-(S) HCl .
Trimetoquinol .
AQ 110 .
AQ110 .
AQL 208 .
AQL208 .
CV 705 .
CV705 .
Trimethoquinol .
An adrenergic beta-agonist used as a bronchodilator agent in asthma therapy. .
0.47
2137
 
Teprotide .
BPP-9a .
Bradykinin-Potentiating Peptide 9a .
Nonapeptide-Converting Enzyme Inhibitor .
SQ-20881 .
Bradykinin Potentiating Peptide 9a .
Enzyme Inhibitor, Nonapeptide-Converting .
Nonapeptide Converting Enzyme Inhibitor .
Peptide 9a, Bradykinin-Potentiating .
A synthetic nonapeptide (Pyr-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro) which is identical to the peptide from the venom of the snake, Bothrops jararaca. It inhibits kininase II and ANGIOTENSIN I and has been proposed as an antihypertensive agent. .
0.44
0495
 
Aclarubicin .
Aclacin .
Aclaplastin .
MA-144A1 .
NSC-208734 .
MA 144A1 .
MA144A1 .
NSC 208734 .
NSC208734 .
Aclacinomycin A .
An anthracycline produced by Streptomyces galilaeus. It has potent antineoplastic activity. .
0.43
0770